Adam Kadlec
Chief Executive Officer at Rivermark Medical, Inc.
Adam Kadlec active positions
| Companies | Position | Start | End |
|---|---|---|---|
Golden Angels Investors LLC
 Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Consultant / Advisor | 31/03/2018 | - |
Rivermark Medical, Inc.
 Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Director/Board Member | - | - |
| Chief Executive Officer | 31/07/2021 | - | |
| President | 31/07/2021 | - |
Career history of Adam Kadlec
Training of Adam Kadlec
| University of Wisconsin | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| Consultant / Advisor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Golden Angels Investors LLC
Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Finance |
Rivermark Medical, Inc.
Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Health Technology |
- Stock Market
- Insiders
- Adam Kadlec
- Experience
